Filing Details

Accession Number:
0001209191-21-020514
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-15 17:11:01
Reporting Period:
2021-03-12
Accepted Time:
2021-03-15 17:11:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808158 Repare Therapeutics Inc. RPTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1473930 Todd Foley C/O Mpm Capital
450 Kendall Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2021-03-12 376,412 $28.18 2,627,360 No 4 S Indirect See Footnote
Common Shares Disposition 2021-03-15 24,271 $0.00 2,603,089 No 4 J Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 J Indirect See Footnote
Footnotes
  1. The shares were sold as follows: 363,887 by MPM BioVentures 2014, L.P. ("BV 2014") and 12,525 by MPM Asset Management Investors BV2014 LLC ("AM BV2014").
  2. The shares are held as follows: 2,364,040 by BV 2014, 181,948 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 81,372 by AM BV2014. MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV LLC is the manager of AM BV2014. Todd Foley is a managing director of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  3. Represents a pro rata in-kind distribution from BV 2014(B) to its limited partners for no consideration.
  4. The shares are held as follows: 2,364,040 by BV 2014, 157,677 by BV 2014(B) and 81,372 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.